Subscribe Now to GaBI Journal 2017

Read the latest news and development in generics and biosimilars research.

Subscribe now to GaBI Journal.

The scope of GaBI Journal, as one of the umbrella projects of GaBI, is broad and of interest and relevance to professionals active in clinical practice, pharmaceutical science and policy. Materials published in GaBI Journal include high quality research reports, literature reviews and case studies, all of which are peer reviewed.

GaBI Journal publishes independent, high quality, authoritative and peer reviewed scientific articles concerning any aspects of the research into and development of cost-effective medicines, irrespective of their sources.

GaBI Journal publishes manuscripts in all aspects of generic and biosimilar medicines, including but not limited to the development of formulations, production, testing (including equivalence – in vivo and in vitro), model development, regulatory issues, supply chain management and pharmacoeconomics. Experts are highly motivated to share their knowledge and professional experiences through their contributing articles.

    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question
    This is a required question

    Captionless Image

    Contact information

    Pro Pharma Communications International Postbus 10001, BE-2400 Mol, Belgium Tel: +32 14 724 215 • Fax: +32 14 583 048 Email: info@gabi-journal.net V17C10LB GJ Sub Web 2017